Tandem Diabetes Care
TNDM
116 hedge funds and large institutions have $735M invested in Tandem Diabetes Care in 2018 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 18 closing their positions.
595% more capital invested
Capital invested by funds: $106M → $735M (+$630M)
233% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 18
200% more funds holding in top 10
Funds holding in top 10: 2 → 6 (+4)
85% more call options, than puts
Call options by funds: $22.3M | Put options by funds: $12.1M
55% more funds holding
Funds holding: 75 → 116 (+41)
18.99% more ownership
Funds ownership: 47.71% → 66.7% (+19%)
0% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$35.6M |
| 2 |
DM
Deerfield Management
New York
|
+$27.7M |
| 3 |
FAM
Fred Alger Management
New York
|
+$24M |
| 4 |
O
OrbiMed
New York
|
+$20.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$34.8M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$6.68M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$4.33M |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$4.18M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$3.89M |
TNDM Hedge Fund Activity: Q2 2018 in Review
116 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q2 2018, worth a combined $735M — up 595% from $106M a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new TNDM positions and 18 closed out — a net gain of 42 holders — while 24 added to existing stakes and 24 trimmed.
The largest buyer was BlackRock, adding an estimated $35.6M. The largest seller was First Light Asset Management, cutting an estimated $34.8M.
- 116 institutional investors held Tandem Diabetes Care (TNDM) as of Q2 2018, up from 75 in Q1 2018.
- Funds reported $735M of Tandem Diabetes Care stock for Q2 2018, up 595% quarter-over-quarter.
- 60 funds opened new Tandem Diabetes Care positions in Q2 2018 and 18 closed out, a net change of +42 holders.
- The largest Tandem Diabetes Care buyer in Q2 2018 was BlackRock, an estimated $35.6M added.
- The largest Tandem Diabetes Care seller in Q2 2018 was First Light Asset Management, an estimated $34.8M sold.
Based on aggregated 13F filings for Q2 2018.